Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1

Vaccine

Volumn 26, Issue 45, 2008, Pages 5722-5727

  Feunou, Pascal Feunou ^a,b,c   Ismaili, Jamila ^a,b,c   Debrie, Anne Sophie ^a,b,c   Huot, Ludovic ^b,c,d   Hot, David ^b,c,d   Raze, Dominique ^a,b,c   Lemoine, Yves ^b,c,d   Locht, Camille ^a,b,c  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c Molecular and Cellular Medicine   (France)

^d CNRS   (France)

Author keywords

Genetic stability; Live attenuated vaccine; Pertussis

Indexed keywords

BACTERIAL TOXIN; DERMONECROTIC TOXIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

AMPG GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BAGG ALBINO MOUSE; BORDETELLA PERTUSSIS; BORDETELLA PERTUSSIS BPZE1; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; DNT GENE; DRUG STABILITY; FEMALE; GENE DELETION; GENE INACTIVATION; GENETIC STABILITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERTUSSIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTX GENE; SEQUENCE ANALYSIS;

ANIMALS; BORDETELLA PERTUSSIS; FEMALE; MICE; MICE, INBRED BALB C; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERTUSSIS VACCINE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; VACCINATION; VACCINES, ATTENUATED; WHOOPING COUGH;

EID: 53149104723     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.018     Document Type: Article

References (20)

1. Alexanderson S. Advantages and disadvantages of using live vaccines. Risks and control measures. Acta Vet Scand Suppl 90 (2006) 89-100
2. Hopkins B.A., and Olson L.D. Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys. Avian Dis 41 (1997) 317-325
3. Kotloff K.L., Noriega F., Losonsky G.A., Sztein M.B., Wasserman S.S., Nataro J.P., et al. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect Immun 64 (1996) 4542-4548
4. Levine M.M., and Kaper J.B. Live oral vaccines against cholera: an update. Vaccine 11 (1993) 207-212
5. Mielcarek N., Riveau G., Remoué F., Antoine R., Capron A., and Locht C. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis. Nat Biotechnol 16 (1998) 454-457
6. Mielcarek N., Debrie A.S., Raze D., Bertout J., Rouanet C., Younes A.B., et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2 (2006) e65
7. Kariyawasam S., Wilkie B.N., and Gyles C.L. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli. Avian Dis 48 (2004) 287-299
8. Locht C. Live bacterial vectors for intranasal delivery of protective antigens. Pharm Sci Technol Today 4 (2000) 121-128
9. Locht C., Antoine R., and Jacob-Dubuisson F. Bordetella pertussis, molecular pathogenesis under multiple aspects. Curr Opin Microbiol 4 (2001) 82-89
10. World Health Organization (WHO). The world health report 2004-changing history. Geneva: WHO; 2004. Available: http://www.who.int/whr/2004/en.
11. Menozzi F.D., Mutombo R., Renauld G., Gantiez C., Hannah J.H., Leininger E., et al. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect Immun 62 (1994) 769-778
12. Hot D., Antoine R., Renauld-Mongénie G., Caro V., Hennuy B., Levillain E., et al. Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol Genet Genomics 269 (2003) 475-486
13. Caro V., Hot D., Guigon G., Hubans C., Arrive M., Soubigou G., et al. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microbes Infect 8 (2006) 2228-2235
14. Olivier C., Hot D., Huot L., Ollivier N., El-Mahdi O., Gouyette C., et al. Alpha-oxo semicarbazone peptide or oligodeoxynucleotide microarrays. Bioconjug Chem 14 (2003) 430-439
15. Smyth G.K., Yang Y.H., and Speed T.P. Statistical issues in microarray data analysis. Methods Mol Biol 224 (2003) 111-136
16. Kim C.C., Joyce E.A., Chan K., and Falkow S. Improved analytical methods for microarray-based genome-composition analysis. Genome Biol 3 11 (2002) [RESEARCH0065]
17. Stibitz S. The bvg regulon. In: Locht C. (Ed). Bordetella pertussis molecular biology (2007), Horizon Bioscience, Norfolk, U.K. 47-67
18. Kirillov M.Y., Shumakov Y.L., Nechaeva E.V., Butcher S., Sinjashina L., Runeberg K., et al. Repeated sequences isolated from Bordetella pertussis induce DNA rearrangements and deletions at high frequency. Gene 166 (1995) 111-116
19. Parkhill J., Sebaihia M., Preston A., Murphy L.D., Thomson N., Harris D.E., et al. Comparative analysis of the genome sequendes of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35 (2003) 32-40
20. Kuhl S.A., McCreary R.P., Bannan J.D., and Friedman R.L. Isolation and characterization of the recA gene of Bordetella pertussis. Mol Microbiol 4 (1990) 1165-1172